Fig. 2From: Long-term evaluation of the seroprevalence of SARS-CoV-2 IgG and IgM antibodies in recovered patients: a meta-analysisForest plot showing the seroprevalences of IgG antibodies in recovered COVID-19 patients. Effect estimates are reported with 95% confidence intervals (CIs) and p-valuesBack to article page